Dermatology NewsGuselkumab tops secukinumab over 48 weeks for plaque psoriasisJanuary 29, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsComorbidities may cut effectiveness of psoriasis biologicsJanuary 25, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsBrodalumab raced past ustekinumab to PASI 100January 13, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsChronic infections such as HCV, HIV, and TB cause unique problems for psoriasis patientsJanuary 9, 2019PsoriasisInfectious Diseases
Dermatology NewsLongterm maintenance of PASI 75 responses observed with tildrakizumabJanuary 3, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsCONDOR trial: Most psoriasis patients can be downshifted to reduced-dose biologicsJanuary 3, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsAlgorithm proposes approach for managing TNF inhibitor–induced psoriasisDecember 13, 2018Psoriatic ArthritisPsoriasisPediatrics
Dermatology NewsWeight loss cuts risk of psoriatic arthritisNovember 29, 2018Psoriatic ArthritisPsoriasis
Dermatology NewsTreating psoriasis with biologics: Recommendations from an expertNovember 19, 2018Psoriasis
Dermatology NewsComorbidities are important in psoriasis careNovember 2, 2018Psoriatic ArthritisPsoriasis
Dermatology NewsOver one-third of psoriasis patients have PsANovember 1, 2018PsoriasisPsoriatic Arthritis
